FDA Approves Second Drug For Active SPMS MStranslate April 1, 2019 Research, Treatments Late last week, it was announced that Mavenclad (cladribine) received US FDA approval for the treatment of adults living with relapsing multiple sclerosis (MS). Importantly, this also includes people living...
